Theratechnologies Enters Exclusive Talks with New Suitors Amid Future Pak's Acquisition Pursuit

Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

April 11, 2025 – Montreal, Canada – Theratechnologies, a Canadian biotechnology company, today responded to Future Pak's press release and announced that it has entered into exclusive discussions with another potential acquiror for the sale of the company.

On April 10, 2025, Future Pak, a US-based biotechnology company, issued a press release stating that it had entered into a non-binding letter of intent to acquire Theratechnologies. In response, Theratechnologies announced that it has received a competing offer from another potential acquiror, which it believes is more favorable to its shareholders.

"We are pleased to have received a competing offer that we believe is more attractive to our shareholders," said Dr. Luc Mongrain, President and CEO of Theratechnologies. "We are committed to maximizing value for our shareholders and we will continue to explore all options to achieve this goal."

Theratechnologies' board of directors has been actively exploring strategic alternatives to optimize the value of the company, including a potential sale. The company's shares have been trading at a significant discount to their historical levels, and the board believes that a sale could be an attractive way to unlock value for shareholders.

The exclusive discussions with the new acquiror are ongoing, and Theratechnologies expects to provide an update on the status of these discussions in the near future.

About Theratechnologies Theratechnologies is a Canadian biotechnology company that is focused on developing innovative therapies for the treatment of chronic diseases. The company's lead product, an HIV treatment, is currently in Phase III clinical trials.

Contact: Dr. Luc Mongrain President and CEO Theratechnologies lmongrain@theratech.com (514) 742-2400

Note: This is a summary article, and the original source may contain additional information.